PortViewPortView
Neogen logo

Neogen (NEOG) Stock Analysis

NASDAQHealthcareMedical - Devices

$11.83+1.63%
1-year price historyRange $5.27 – $12.15
52-week range$11.83
$4.90$12.85

What Neogen does

Neogen Corporation, including its affiliated companies, is a global leader in creating, manufacturing, and distributing a wide range of products crucial for maintaining food quality and animal health. The enterprise is structured into two primary divisions: Food Safety and Animal Safety. The Food Safety segment delivers advanced diagnostic test kits and associated solutions to identify detrimental or unintended contaminants in food and animal feed. This extensive detection capability covers threats such as foodborne pathogens, spoilage-causing organisms, naturally occurring toxins, food allergens, genetically modified ingredients, ruminant by-products, specific meat identification, residual drugs and pesticides, and overall sanitation issues. A key product is the AccuPoint Advanced rapid sanitation test, which quickly spots adenosine triphosphate (ATP), indicating the presence of living cells, to verify cleanliness. Customers for this segment are diverse, encompassing producers and processors of food and feed, grain operations, manufacturers of processed foods like cookies, crackers, candy, and ice cream, as well as those handling meat, poultry, seafood, fruits, vegetables, and dairy. It also serves laboratories and producers of pharmaceuticals, cosmetics, and veterinary vaccines. The Animal Safety division provides a comprehensive portfolio for the animal health market. Offerings include veterinary instruments, pharmaceuticals, vaccines, topical medications, parasiticides, diagnostic products, rodenticides, cleaning agents, disinfectants, insecticides, and genomics testing services. This segment also supplies specialized products for researchers investigating biologically active substances. Its immunoassay test kits are vital for detecting illicit and therapeutic drugs in farm and racing animals, identifying drug residues in meat and meat products, and assisting in human forensic toxicology drug screenings. Moreover, products from this division are instrumental in upholding hygienic conditions and minimizing the risks posed by bacteria, fungi, and viruses. Neogen Corporation was established in 1981 and is headquartered in Lansing, Michigan.

Key metrics

Market cap
$2.58B
P/E (TTM)
42.25
EPS (TTM)
$0.28
Beta
1.77
Dividend yield
0.00%
Revenue / share
$4.00
50-day avg
$10.56
200-day avg
$9.28
52-week high
$12.85
52-week low
$4.90
CEO
Mikhael Nassif

ETFs linked to NEOG

Broad-market and Healthcare sector ETFs an investor holding Neogen is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NEOG fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NEOG in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Neogen?
Neogen trades under the ticker NEOG on NASDAQ.
Which exchange is NEOG listed on?
NEOG is listed on NASDAQ.
What sector does Neogen operate in?
Neogen is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NEOG in a portfolio?
PortView shows NEOG's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.